2-(2,6-Difluoro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

Biphenyl-3-carboxylic Acid>98.0%(GC)(T)1g

3-Amino-1-boc-4-methylpiperidine, 98.0%, 250mg

3-(3,4-difluorophenyl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 500mg

(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid, 97.0%, 100mg

Methyl 5-bromo-6-chloropicolinate, 95.0%, 100g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 150, 5000 ml, 190 mm, 1 Piece

N-(tert-Butoxycarbonyl)-2-methyl-1,3-diaminopropane>98.0%(GC)(T)1g

3-ethoxycyclopent-2-en-1-one, 95.0%, 5g

Methyl 2-((tert-butyldimethylsilyl)oxy)acetate, 97%, 25g

4H-Thieno[3,2-b]pyrrole-5-carboxylic acid, 95.0%, 250mg

L-Histidine Hydrochloride Monohydrate, 250g, >=98.5%, Ph. Eur., for Biochemistry

7-Nitro-1,2,3,4-tetrahydroquinoline>98.0%(GC)(T)5g